Clinical Trials · NCT02072096
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Eli Lilly and Company
- Enrollment
- 192
- Start date
- Feb 2014
- Locations
- 34 sites, 5 countries
- Primary endpoint
- Percentage of Participants Achieving and Maintaining Individualized Glycated Hemoglobin A1c (HbA1c) Targets Without Clinically Significant Hypoglycemia